Anaesthesia & Pain Medicine

Finding suitable patients who meet the specific criteria for anaesthesia and pain medicine trials can be challenging. Additionally, ensuring that these patients remain engaged and complete the study often poses significant hurdles.

iNGENū CRO addresses this pain point with Enhanced Recruitment Strategies

iNGENū leverages advanced patient databases to identify suitable candidates rapidly. We also ensure continuous engagement and use patient-centric approaches, such as flexible scheduling and remote monitoring, to maximize retention.

Pain is subjective, and its measurement can vary between patients and evaluators. This makes consistent assessment difficult.

iNGENū addresses this pain point with Standardisation

We implement standardised and validated pain assessment tools. We also offer training sessions for clinical staff on the consistent use and interpretation of these tools, ensuring uniformity across all trial sites.

Given the subjective nature of pain, placebo effects can be profound in pain medicine trials. Ensuring effective blinding can be challenging.

iNGENū addresses this pain point with Robust Blinding Methodologies

iNGENū designs trials with robust blinding methodologies, minimising potential biases. We also use advanced statistical techniques to account for and analyse placebo responses, ensuring the integrity of the trial results.

As anaesthesia and pain medications often have systemic effects, monitoring for adverse events and ensuring patient safety is critical.

iNGENū addresses this pain point with Safety Monitoring

We employ state-of-the-art safety monitoring systems and protocols. Our dedicated safety board reviews data in real-time, ensuring rapid response to any adverse events. With a focus on patient well-being, we prioritise transparent communication with all stakeholders about potential risks and safety measures.